MAPK1 and neoplasm: Increased activation of the ERK/MAPK signaling pathway can promote the transformation of normal cells into cancer cells, whereas inhibition of the ERK/MAPK signaling pathway can revert cancer cells to a non-transformed state in vitro and can inhibit tumor growth in vivo.